References
Clark DWJ (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29:342–375
Eichelbaum M (1982) Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokin 7:1–22
Eichelbaum M (1983) Genetische Polymorphismen des oxidativen Arzneimittelstoffwechsels. Therapeutische und toxikologische Implikationen. Internist 24:117–127
Eichelbaum M (1988) Genetic polymorphism of sparteine/debrisoquine oxidation. ISI Atlas of Science: Pharmacology (In press)
Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16:183–187
Eichelbaum M, Bertilsson L, Säwe J, Zekorn C (1982) Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities. Clin Pharmacol Ther 31:184–186
Eichelbaum M, Bertilsson L, Säwe J (1983) Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine. Br J Clin Pharmacol 15:317–321
Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331:442–446
de Vries JX, Walter-Sack I, Ittensohn A (1987) Analysis of benzbromarone in human plasma and urine by high performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr 417:420–427
de Vries JX, Walter-Sack I, Löffler W (1987) The biotransformation of benzbromarone in humans. Characterization of a new metabolite by gas chromatography-mass spectrometry. Klin Wochenschr 65, Suppl X:10
Walter-Sack I, de Vries JX, Ittensohn A, Kohlmeier M, Weber E (1988) Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone. Klin Wochenschr 66:160–166
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walter-Sack, I., Eichelbaum, M., de Vries, J.X. et al. Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine. Klin Wochenschr 66, 1097–1098 (1988). https://doi.org/10.1007/BF01711926
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711926